initial public offerings (IPOs) trading on American exchanges
Showing posts with label 2013 IPOs. Show all posts
Showing posts with label 2013 IPOs. Show all posts

Thursday, July 30, 2026

==Silvercrest Asset Management (SAMG)

Silvercrest Asset Management Group Inc. completed its initial public offering on June 27, 2013, trading on the NASDAQ under the ticker symbol SAMG.

Founded in 2002, the New York-based wealth management firm focuses on ultra-high-net-worth individuals, families, and institutional investors.


IPO and Offering Details
  • Date: June 27, 2013 (effective June 26, 2013)
  • Exchange / Ticker: NASDAQ: SAMG
  • Shares Offered: ~4.8 million shares
  • Price Range: $12 to $14 per share
  • Capital Raised: ~$62 million
  • Lead Underwriters: Sandler O’Neill + Partners and Raymond James
Initial Delay: Silvercrest initially filed for a $55 million IPO in September 2012, but formally withdrew it in November 2012 citing unfavorable market valuations.

Thursday, March 27, 2025

ADMA Biologics (ADMA)

ADMA Biologics makes human-derived immunoglobulin. Its products treat people whose bodies don't make enough antibodies to ward off illnesses from common viruses. Instead of risking illness, people with primary immunodeficiency receive regular infusions of ADMA's drugs.
  • Sector: Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 685
  • Founded by Adam S. Grossman and Jerrold B. Grossman in 2004  
  • Headquartered in Ramsey, New Jersey
  • https://www.admabiologics.com/
IPO: October 17, 2013







ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. 


ADMA's biggest moneymaker, Asceniv. 
ADMA Biologics developed Asceniv in-house. It's a cocktail created from super donors whose plasma has a high level of antibodies capable of handling respiratory syncytial virus, or RSV. RSV leads to cold symptoms in most people, but it can be serious in people with compromised immune systems.

Last year, Asceniv generated $216.7 million in sales. This year, it's expected to bring in $283 million, growing almost 31%. Earnings are also promising. In 2024, ADMA Biologics earned 49 cents per share, flipping from no earnings in the year-earlier period. This year, it's expected to notch a 71-cent profit, up 45%.

Asceniv accounts for slightly more than half of ADMA's total sales. The company also sells Bivigam and Nabi-HB, two products it acquired. Bivigam provides various antibodies found in a healthy immune system, while Nabi-HB protects against hepatitis B in people who've been exposed.
 

Tuesday, December 31, 2024

U.S.-listed IPOs, annual deal count and value

The value of new U.S. stock listings has only ticked up modestly from 2022, when rapidly rising interest rates and COVID-related distortions in some industries depressed IPO activity.

As of December 31, 2024. Source: Bloomberg Finance L.P.

Friday, December 1, 2023

DDC Enterprise (DDC) began trading on the NYSE on Fri 17 Nov 23

DDC Enterprise Limited provides ready-to-heat, ready-to-cook, and ready-to-eat plant-based meal products in Hong Kong and internationally. It also provides marketplace, advertising, and content distribution and placement services to third-party brands and products. 
  • Sector: Consumer Defensive
  • Industry: Packaged Foods
  • Full Time Employees: 104
  • Incorporated in 2012 
  • Based in Sheung Wan, Hong Kong
  • https://ir.daydaycook.com
 Ticker: DDC



Ms. Norma Chu and Daydaycook at the NYSE



Sunday, May 20, 2018

Physicians Realty Trust (DOC) : 5-year performance

  • March 01, 2024: Healthpeak Properties, Inc. (NYSE: PEAK) today announced that it has closed on the previously announced merger with Physicians Realty Trust (DOC). The combined company will operate under the name “Healthpeak Properties, Inc.” and is expected to begin trading under the ticker symbol “DOC” at the open of trading on The New York Stock Exchange on March 4, 2024.
------------
Real estate investment trust company (REIT)
Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.
  • Headquarters: Wisconsin
  • Founded: 2013
  • Sector: Real Estate
  • Industry: REIT - Healthcare Facilities
  • Full Time Employees: 63
  • Forward Dividend & Yield 0.92 (5.97%)
  • docreit.com



  






Saturday, October 21, 2017

CyrusOne (CONE) : 4-year performance

Data center REIT.   The company owns 35 operating data center facilities in 11 markets.
  • Headquarters: Dallas, TX
  • Founded 2001;  IPO in Jan 2013
  • cyrusone.com

 



Description

CyrusOne Inc. is a real estate investment trust. The Company is an owner, operator and developer of enterprise-class, carrier-neutral, multi-tenant data center properties. The Company's data centers are generally purpose-built facilities with redundant power and cooling. The CyrusOne National IX Platform (the National IX Platform) delivers interconnection across states and between metro-enabled sites within its footprint and beyond. The Company has data centers in the United States, London and Singapore. As of December 31, 2016, the Company provided mission-critical data center facilities for 932 customers in 35 data centers and two recovery centers in 11 distinct markets (nine cities in the United States, London and Singapore) with approximately 3,904,000 net rentable square feet (NRSF). The Company provides round the clock security guard monitoring with customizable security features. As of December 31, 2016, the Company had approximately 1,657,000 NRSF under development.

Key stats and ratios

Q2 (Jun '17)2016
Net profit margin-0.48%3.76%
Operating margin9.83%13.32%
EBITD margin-49.90%
Return on average assets-0.09%0.79%
Return on average equity-0.29%1.94%
Employees380

Tuesday, April 18, 2017

American Homes 4 Rent (AMH)

American Homes 4 Rent is a real estate investment trust based in Calabasas, California that invests in single-family rental homes.  Its largest concentrations are in Atlanta (9.3% of total homes), Dallas-Fort Worth (8.4% of total homes), and Charlotte, North Carolina (7.2% of total homes).

Tuesday, July 1, 2014

Autohome (ATHM) : 7-month performance


Ticker: ATHM
Autohome Inc. operates as an online destination for automobile consumers in the People's Republic of China. The company through its Websites, autohome.com.cn and che168.com delivers independent and interactive content to automobile buyers and owners, including professionally produced content that comprises automobile-related articles and reviews, pricing trends in various markets, and photos and video clips; automobile library, which includes a range of specifications covering performance levels, dimensions, powertrains, vehicle bodies, interiors, safety, entertainment systems, and other unique features, as well as manufacturers' suggested retail prices; new and used automobile listings, and promotional information; and user forums and user generated content. Autohome Inc. also offers advertising services for automakers and dealers; dealer subscription services that allow dealers to market their inventory and services through its Websites; used automobile listings services, which allow used automobile dealers and individuals to market their automobiles for sale on its Websites; and automobile dealer subscription services that enable dealers to establish and maintain online showrooms of automobiles with pricing and promotional information on autohome.com.cn. In addition, it operates automotive aftermarket services platform that integrates services descriptions and pricing information into a database that enables its users to identify and research local automobile services shops, schedule various services with them, and offer real-time feedback on the service providers; provides iOS- and Android-based applications to allow its users to access its content; and offers technical and consulting services. The company was formerly known as Sequel Limited and changed its name to Autohome Inc. in October 2011. The company was founded in 2008 and is headquartered in Beijing, the People's Republic of China. Autohome Inc. is a subsidiary of Telstra Holdings Pty Ltd.

As of December 31, 2013, it had over 8.3 million registered users and over 1,500 user forums. As of December 31, 2013, it had an online automobile library in China with nearly 16,000 vehicle model configurations and over 2.2 million photos. Its automobile listing information features listings of both new and used automobiles on its Websites.


Address

10th Floor Tower B, CEC Plaza, 3 Dan Ling Street, Haidian District
BEIJING, BEJ 100080
China

Key stats and ratios

Q1 (Mar '14)2013
Net profit margin35.65%37.50%
Operating margin43.36%45.61%
EBITD margin-48.84%
Return on average assets14.00%15.48%
Return on average equity21.42%24.20%
Employees1,191

Friday, April 11, 2014

LDR Holding (LDRH) began trading on the NASDAQ on 9 October 2013


Description

LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and surgical technologies for the treatment of patients suffering from spine disorders. The Company’s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company’s VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company’s Mobi non-fusion platform is highlighted by Mobi-C, a cervical disc replacement device with a patented mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc.

Address

Suite 200, 13785 Research Boulevard
AUSTIN, TX 78750-1873
United States

Key stats and ratios

Q4 (Dec '13)2013
Net profit margin-47.24%-25.03%
Operating margin-2.83%-2.08%
EBITD margin-1.52%
Return on average assets-58.92%-26.66%
Return on average equity-341.85%-118.87%
Employees29

Phillips 66 Partners (PSXP) began trading on the NYSE on 23 July 2013

Just over 16.4 million common units in the partnership were released in the IPO. The public will collectively hold a nearly 23% limited partner interest in the enterprise, or as much as 26% if the offering's underwriters fully exercise their option to purchase 2.46 million additional units.


The company is a limited partnership created earlier this year by downstream oil concern Phillips 66 (NYSE: PSX) . In the words of its parent, Partners was formed to "own, operate, develop, and acquire primarily fee-based crude oil, refined petroleum product, and natural gas liquids pipelines and terminals and other transportation and midstream assets." Partners is a spinoff of a spinoff; Phillips 66 was carved out of energy major ConocoPhillips (NYSE: COP) and made its market debut in 2012.

Description

Phillips 66 Partners LP owns, operates, develops and acquires primarily fee-based crude oil, refined petroleum product and natural gas liquids (NGL) pipelines and terminals and other transportation and midstream assets. The Company’s initial assets consist of the three systems, which include Clifton Ridge crude system, Sweeny to Pasadena products system and Hartford Connector products system. A refined petroleum product pipeline, terminal and storage system extending from Phillips 66’s Sweeny refinery in Old Ocean, Texas, to its refined petroleum product terminal in Pasadena, Texas, and ultimately connecting to the Explorer and Colonial refined petroleum product pipeline systems and other third-party pipeline and terminal systems.
The company was founded in 2013 and is headquartered in Houston, Texas.

Address

3010 Briarpark Drive
HOUSTON, TX 77042
United States

Monday, March 17, 2014

Five Prime Therapeutics (FPRX) began trading on the NASDAQ on 18 September 2013



3/17/2014 chart update (daily)

Description

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. Protein therapeutics is antibodies or drugs developed from extracellular proteins or protein fragments that block disease processes, including cancer and inflammatory diseases. The Company’s advanced product candidates include FP-1039/GSK3052230 (FP-1039), FPA008 and FPA144. FP-1039 is a protein therapeutic that traps and neutralizes cancer-promoting fibroblast growth factors (FGFs), involved in cancer cell proliferation and new blood vessel formation. FPA008 is an antibody that inhibits colony stimulating factor-1 receptor (CSF1R), and is being developed to treat patients with inflammatory diseases, including rheumatoid arthritis (RA). FPA144 is an antibody that inhibits FGF receptor 2b (FGFR2b), and is being developed to treat patients with gastric cancer and potentially other solid tumors.

Address

Two Corporate Drive
SOUTH SAN FRANCISCO, CA 94080
United States 

Key stats and ratios

Q3 (Sep '13)2012
Net profit margin-207.75%-276.42%
Operating margin-210.17%-278.51%
EBITD margin--262.06%
Return on average assets-45.55%-53.75%
Return on average equity--
Employees107

Thursday, March 6, 2014

Kamada (KMDA) began trading on the NASDAQ on 31 May 2013


Description

Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology. It offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The Company’s product line includes intravenous AAT for chronic replacement therapy in individuals with congenital alpha-1 antitrypsin deficiency; KamRAB for prophylaxis of rabies infection; KamRho-D IM for prophylaxis of Rh hemolytic disease of the newborn; KamRho-D IV for treatment of immune thrombocytopenic purpura; and IVIG, a replacement therapy in primary and secondary immune therapy. Its product line also comprises Protosol to reduce blood loss in patients undergoing cardiac surgery; Heparin sodium injection for coagulation inhibition and prophylaxis of thromboembolic diseases and Heparin Lock Flush to maintain potency of intravenous injection device among other.

Address

7 Sapir St. Kiryat Weizmann Science Park, P.O Box 4081
NESS-ZIONA, 74140
Israel

Applied Optoelectronics (AAOI) began trading on the NASDAQ on 26 September 2013


Description

Applied Optoelectronics, Inc. is a vertically integrated provider of fiber-optic networking products, primarily for three networking end-markets: cable television, (CATV), fiber-to-the-home (FTTH), and Internet data centers. The Company designs and manufactures a range of optical communications products at varying levels of integration, from components, subassemblies and modules to complete turn-key equipment. The Company designs, manufactures and integrates its own analog and digital lasers using a Molecular Beam Epitaxy (MBE), fabrication process. The Company’s solutions enable customers to deliver products; enhance efficiency and cost effectiveness of its customers' supply chain; deliver high quality, reliable products in high volume; and provide sophisticated design solutions to its customers. The Company manufactures the majority of the laser chips and optical components that are used in its products.

Address

13115 Jess Pirtle Blvd.
SUGAR LAND, TX 77478
United States 

Key stats and ratios

Q4 (Dec '13)2013
Net profit margin-2.19%-1.79%
Operating margin-1.25%-0.39%
EBITD margin--0.39%
Return on average assets-2.23%-1.59%
Return on average equity--2.99%
Employees927

Ophthotech (OPHT) began trading on the NASDAQ on 25 September 2013


Description

Ophthotech Corporation is a biopharmaceutical company specializing in the development of therapeutics to treat diseases of the eye. The Company’s advanced product candidate is Fovista, which the Company is developing for use in combination with anti-VEGF drugs that represent the current standard of care for the treatment of wet age-related macular degeneration (wet AMD). Wet AMD is a serious disease of the central portion of the retina, known as the macula, which is responsible for detailed central vision and color perception. It is characterized by abnormal new blood vessel formation and growth, referred to as neovascularization, which results in blood vessel leakage, retinal distortion and scar formation. If untreated, the progressive retinal damage results in rapid, irreversible and severe vision loss. Wet AMD is the cause of blindness in patients over the age of 55 in the United States and the European Union.

Address

35th Floor One Penn Plaza
NEW YORK, NY 10119
United States

Key stats and ratios


Q4 (Dec '13)2013
Net profit margin--
Operating margin--
EBITD margin--
Return on average assets--
Return on average equity--
Employees22


Friday, February 28, 2014

Zoetis (ZTS) began trading on the NYSE on 1 February 2013



Description


Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The primary livestock species are cattle (both beef and dairy), swine, poultry, sheep and fish, and the primary companion animal species are dogs, cats and horses. In February 2014, Benchmark Holdings PLC purchased aquaculture vaccine and development assets from animal health company Zoetis Inc.

Address

100 Campus Drive
FLORHAM PARK, NJ 07932
United States

Key stats and ratios

Q3 (Sep '13)2012
Net profit margin11.88%10.06%
Operating margin16.77%16.37%
EBITD margin-25.25%
Return on average assets8.39%7.28%
Return on average equity63.96%11.26%
Employees9,300

Tuesday, February 25, 2014

Stock Building Supply Holdings, Inc. (STCK) began trading on the NASDAQ on 8 August 2013

Stock Building Supply Holdings, Inc. engages in the distribution of lumber and building materials in the United States. It was founded in 1922 and is headquartered in Raleigh, North Carolina.




Stock Building Supply Holdings, Inc. engages in the distribution of lumber and building materials in the United States. The company provides millwork and other interior products comprising interior doors, interior trim, custom millworks, moldings, stairs and stair parts, flooring, cabinets, gypsum, and other products for inside the structure of the home; and lumber and lumber sheet goods, such as dimensional lumber, plywood, and oriented strand board products for on-site house framing. It also offers windows and other exterior products consisting of exterior door units, and roofing and siding products; and hardware, boards, and insulation products, as well as design assistance and professional installation services of products. In addition, the company manufactures and sells structural components, including floor trusses, roof trusses, wall panels, and engineered wood product. It serves production and custom homebuilders; and repair and remodel, multi-family, and commercial contractors. The company was formerly known as Saturn Acquisition Holdings, LLC and changed its name to Stock Building Supply Holdings, Inc. in May 2013.
Stock Building Supply Holdings, Inc. was founded in 1922 and is headquartered in Raleigh, North Carolina.

Description

Stock Building Supply Holdings, Inc. is a diversified lumber and building materials (LBM) distributor and solutions provider that sells to new construction and repair and remodel contractors. The Company’s primary products are lumber & lumber sheet goods, millwork, doors, flooring, windows, structural components, such as engineered wood products (EWP), trusses, wall panels and other exterior products. The Company serves a customer base, including large-scale production homebuilders, custom homebuilders and repair and remodeling contractors. In addition, the Company provides solution-based services to its customers, including design, product specification and installation management services. The Company’s primary operating regions include the South and West regions of the United States.

Address

Suite 400, 8020 Arco Corporate Drive
RALEIGH, NC
United States 

Key stats and ratios

Q3 (Sep '13)2012
Net profit margin-1.71%-1.55%
Operating margin-0.89%-2.01%
EBITD margin--0.42%
Return on average assets-6.44%-5.39%
Return on average equity-30.77%-56.23%
Employees2,557